Showing results (151-160 of 757) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infectionMarion Delphin, Khadija Said Mohammed, Louise O Downs, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2023
Upfront endoscopic necrosectomy or step-up endoscopic approach for infected necrotising pancreatitis (DESTIN): a single-blinded, multicentre, randomised trialJi Young Bang, Sundeep Lakhtakia, Shyam Thakkar, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2023
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trialQi Liu, Junqiang Chen, Yu Lin, et al.
The Lancet. Gastroenterology & Hepatology|July 21, 2023
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysisElton Dajti, Federico Ravaioli, Romanas Zykus, et al.
The Lancet. Gastroenterology & Hepatology|July 7, 2023
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysisDaniel Q Huang, Nabil Noureddin, Veeral Ajmera, et al.
The Lancet. Gastroenterology & Hepatology|August 19, 2023
NASH drug treatment development: challenges and lessonsHerbert Tilg, Christopher D Byrne, Giovanni Targher
The Lancet. Gastroenterology & Hepatology|June 29, 2023
Fibroblasts in liver cancer: functions and therapeutic translationSilvia Affo, Aveline Filliol, Gregory J Gores, et al.
The Lancet. Gastroenterology & Hepatology|June 16, 2023
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practiceMatthias Pinter, Bernhard Scheiner, David J Pinato
The Lancet. Gastroenterology & Hepatology|June 17, 2023
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trialJoseph A Murray, Dina Wassaf, Karen Dunn, et al.
The Lancet. Gastroenterology & Hepatology|February 20, 2026
Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose studyFrank Erhard Uschner, Martin McCoy, Olaf Tyc, et al.
Pageof 76